
Lung Disease in AATD: Potential Pulmonary Manifestations of Below-Normal AAT Levels
Learn more
This website contains promotional content and is intended for Healthcare Professionals based in the United States only.



This article offers a practical, evidence-based overview of FVIII infusion, dosing, administration, and the management of key clinical challenges, including inhibitor development and strategies that support individualized, patient-centered care.

Click to download additional information about dosing and other gaps in available therapy types

Click to download an overview of the benefits of targeting high sustained FVIII levels

Infographic: view factor IX differences
MAT-US-2405607-v1.0-06/2024